SNOMED procedure and product codes for MMRV vaccines

Please see the published letter on the introduction of a routine varicella vaccination programme for children at one year and at 18 months, with a catch-up for children aged up to 6 years.

Please also see below the SNOMED procedure and product codes that will need to be used for recording MMRV vaccines, which are due to be administered as part of the routine childhood schedule from 1 January 2026. Both procedure and product codes should be recorded when an MMRV vaccine is given. 

MMRV procedure codes:

432636005 | Administration of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)

433733003 | Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)

MMRV product codes:

45480711000001107 | ProQuad vaccine powder and solvent for suspension for injection 0.5ml pre-filled syringes (Merck Sharp & Dohme (UK) Ltd) (product)

45525711000001102 | Priorix Tetra vaccine powder and solvent for solution for injection 0.5ml pre-filled syringes (GlaxoSmithKline UK Ltd) (product)

Please note the ProQuad and Priorix Tetra products have both now been released in the dictionary of medicines and devices (dm+d).  We expect ProQuad to be included in the October release of the SNOMED CT UK Drug Extension (release date 29 October 2025) and Priorix Tetra to be included in the November release (release date 26 November 2025).

Please also note that a fourth dose of DTaP/IPV/Hib/HepB (hexavalent) vaccine will start being routinely administered to eligible children at the new 18-month appointment from 1 January 2026.

2427211000000109 | Fourth diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination (procedure)

For more details on eligibility, please refer to Changes to the routine childhood vaccination schedule from 1 July 2025 and 1 January 2026 letter – GOV.UK

We would like to request that you share the information in this email with your system suppliers as necessary.

UKHSA also sent out details of a webinar that they are holding that practices could register their interest to attend, where they will cover all of the programme details.  Here is the joining link (online event will start at 2pm on Wednesday 3 Dec)

Please contact our team directly with any queries at england.londonimms@nhs.net  For queries about the online webinar, please contact UKHSA directly or look at their website.

Kind regards

London Immunisation Team

NHS England – London Region